Zhao; Zuchun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhao; Zuchun.The latest application filed is for "heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders".

Company Profile

0.39.44

Zhao; Zuchun - Pleasanton CA
Zhao; Zuchun - Hayward CA
Zhao; Zuchun - Richmond CA
Zhao; Zuchun - El Sobrante CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,925,189 - Chen , et al. March 27, 2	2018-03-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20180021335 - Chen; Xin ; et al.	2018-01-25
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,737,537 - Chen , et al. August 22, 2	2017-08-22
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20170105993 - Chen; Xin ; et al.	2017-04-20
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20150239881 - Chen; Xin ; et al.	2015-08-27
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,975,258 - Chen , et al. March 10, 2	2015-03-10
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,921,350 - Chen , et al. December 30, 2	2014-12-30
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,846,675 - Ma , et al. September 30, 2	2014-09-30
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20140024830 - Chen; Xin ; et al.	2014-01-23
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20130281691 - Chen; Xin ; et al.	2013-10-24
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20120322804 - Ma; Jingyuan ; et al.	2012-12-20
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,288,384 - Chen , et al. October 16, 2	2012-10-16
2,4-disubsituted thiazoles and pharmaceutical compositions thereof Grant 8,227,495 - Chen , et al. July 24, 2	2012-07-24
Aryl Gpr119 Agonists And Uses Thereof App 20120184572 - Song; Jiangao ; et al.	2012-07-19
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,183,381 - Ma , et al. May 22, 2	2012-05-22
Aryl Gpr119 Agonists And Uses Thereof App 20110294836 - Song; Jiangao ; et al.	2011-12-01
Modulators Of Glucose Homeostasis For The Treatment Of Diabetes And Metabolic Disorders App 20110160222 - Chen; Xin ; et al.	2011-06-30
Aryl Gpr120 Receptor Agonists And Uses Thereof App 20100216827 - Ma; Jingyuan ; et al.	2010-08-26
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100130511 - CHEN; XIN ; et al.	2010-05-27
Process for the stereoselective preparation of (-)-halofenate and derivatives thereof Grant 7,714,131 - Zhu , et al. May 11, 2	2010-05-11
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100087465 - Chen; Xin ; et al.	2010-04-08
Modulators Of Ppar And Methods Of Their Preparation App 20100087468 - ZHU; Yan ; et al.	2010-04-08
Substituted phenylacetic acids Grant 7,642,358 - Zhao , et al. January 5, 2	2010-01-05
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-- yl}-pyrimidine Grant 7,638,541 - Chen , et al. December 29, 2	2009-12-29
Modulators of PPAR and methods of their preparation Grant 7,622,491 - Zhu , et al. November 24, 2	2009-11-24
Oxymethylene Aryl Compounds And Uses Thereof App 20090270404 - Wilson; Maria E. ; et al.	2009-10-29
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090137590 - Ma; Jingyuan ; et al.	2009-05-28
Resolution Of Alpha-(phenoxy)phenylacetic Acid Derivatives With Naphthyl-alkylamines App 20090093650 - Cheng; Peng ; et al.	2009-04-09
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090054475 - Chen; Xin ; et al.	2009-02-26
Alpha-(trifluoromethyl-substituted Aryloxy, Arylamino, Arylthio Or Arylmethyl)-trifluoromethyl-substituted Phenylacetic Acids And Derivatives As Antidiabetic Agents App 20080287441 - Zhao; Zuchun ; et al.	2008-11-20
Resolution of .alpha.-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines Grant 7,432,394 - Cheng , et al. October 7, 2	2008-10-07
.alpha.-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents Grant 7,371,888 - Zhao , et al. May 13, 2	2008-05-13
Substituted Triazoles As Modulators Of Ppar And Methods Of Their Preparation App 20080108630 - Zhu; Yan ; et al.	2008-05-08
Substituted triazoles as modulators of PPAR and methods of their preparation Grant 7,323,480 - Zhu , et al. January 29, 2	2008-01-29
Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2	2007-09-11
Resolution of alpha-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines App 20070073082 - Cheng; Peng ; et al.	2007-03-29
Process for the stereoselective preparation of (-)-halofenate and derivatives thereof App 20070072858 - Zhu; Yan ; et al.	2007-03-29
Substituted phenylacetic acids App 20060264630 - Zhao; Zuchun ; et al.	2006-11-23
Substituted phenylacetic acids Grant 7,078,421 - Zhao , et al. July 18, 2	2006-07-18
Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al.	2006-06-22
Modulators of PPAR and methods of their preparation App 20060058301 - Zhu; Yan ; et al.	2006-03-16
Substituted triazoles as modulators of PPAR and methods of their preparation App 20060014809 - Zhu; Yan ; et al.	2006-01-19
Bicyclic, Substituted Triazoles As Modulators Of Ppar And Methods Of Their Preparation App 20060014785 - Zhu; Yan ; et al.	2006-01-19
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2	2005-12-20
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2	2005-12-06
Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents App 20050222213 - Zhao, Zuchun ; et al.	2005-10-06
N-heterocyclic derivatives as NOS inhibitors Grant 6,887,865 - Arnaiz , et al. May 3, 2	2005-05-03
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,368 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,864,263 - Arnaiz , et al. March 8, 2	2005-03-08
N-heterocyclic derivatives as NOS inhibitors Grant 6,849,739 - Arnaiz , et al. February 1, 2	2005-02-01
N-heterocyclic derivatives as NOS inhibitors Grant 6,846,829 - Arnaiz , et al. January 25, 2	2005-01-25
N-heterocyclic derivatives as NOS inhibitors Grant 6,841,674 - Arnaiz , et al. January 11, 2	2005-01-11
N-heterocyclic derivatives as nos inhibitors Grant 6,841,673 - Arnaiz , et al. January 11, 2	2005-01-11
N-heterocyclic derivatives as NOS inhibitors Grant 6,747,031 - Arnaiz , et al. June 8, 2	2004-06-08
Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia App 20040039053 - Luskey, Kenneth L. ; et al.	2004-02-26
Substituted phenylacetic acids App 20040029933 - Zhao, Zuchun ; et al.	2004-02-12
N-heterocyclic derivatives as NOS inhibitors Grant 6,670,473 - Arnaiz , et al. December 30, 2	2003-12-30
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 6,624,194 - Luskey , et al. September 23, 2	2003-09-23
Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al.	2003-08-21
Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al.	2003-07-24
N-heterocyclic derivatives as NOS inhibitors App 20030092678 - Arnaiz, Damian O. ; et al.	2003-05-15
N-heterocyclic derivatives as NOS inhibitors App 20030083332 - Arnaiz, Damian O. ; et al.	2003-05-01
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2	2003-04-29
N-heterocyclic derivatives as NOS inhibitors App 20030078265 - Arnaiz, Damian O. ; et al.	2003-04-24
N-heterocyclic derivatives as NOS inhibitors App 20030073669 - Arnaiz, Damian O. ; et al.	2003-04-17
N-heterocyclic derivatives as NOS inhibitors App 20030069210 - Arnaiz, Damian O. ; et al.	2003-04-10
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2	2003-04-01
N-heterocyclic derivatives as NOS inhibitors App 20030060452 - Arnaiz, Damian O. ; et al.	2003-03-27
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2	2003-03-18
N-heterocyclic derivatives as NOS inhibitors App 20030027794 - Arnaiz, Damian O. ; et al.	2003-02-06
N-heterocyclic derivatives as NOS inhibitors App 20030004137 - Arnaiz, Damian O. ; et al.	2003-01-02
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,498,185 - Arnaiz , et al. December 24, 2	2002-12-24
N-heterocyclic derivatives as NOS inhibitors App 20020183323 - Arnaiz, Damian O. ; et al.	2002-12-05
Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al.	2002-11-28
N-heterocyclic derivatives as NOS inhibitors App 20020165203 - Arnaiz, Damian O. ; et al.	2002-11-07
N-heterocyclic derivatives as NOS inhibitors Grant 6,432,947 - Arnaiz , et al. August 13, 2	2002-08-13
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,380,221 - Arnaiz , et al. April 30, 2	2002-04-30
Ortho-anthranilamide derivatives as anti-coagulants Grant 6,140,351 - Arnaiz , et al. October 31, 2	2000-10-31
Naphthyl-substituted benzimidazole derivatives as anti-coagulants Grant 5,849,759 - Arnaiz , et al. December 15, 1	1998-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.